NextGen Creates Diagnostics Subsidiary for CNS Test Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.